15.1 months median PFS vs 10.6 months with placebo + COTELLIC + ZELBORAF (HR=0.78*; 95% CI, 0.63, 0.97; P=0.0249) 1

View the full TECENTRIQ Prescribing Information

Receive information about TECENTRIQ + COTELLIC + ZELBORAF from your Genentech representative

Find information on financial assistance programs for eligible TECENTRIQ patients

1L=first line; CI=confidence interval; HR=hazard ratio; PFS=progression-free survival; RECIST=Response Evaluation Criteria In Solid Tumors.
*Stratified by baseline lactate dehydrogenase (LDH).
As assessed by the investigator, per RECIST v1.1.